Results 261 to 270 of about 18,395 (294)
Early kinetics of anti-PLA2R-IgG4 predicts rituximab response in membranous nephropathy: a prospective biomarker study. [PDF]
Chen S +7 more
europepmc +1 more source
Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy. [PDF]
Trillini M +20 more
europepmc +1 more source
Evolution of idiopathic membranous nephropathy to class v lupus nephritis: a case report and literature review. [PDF]
Shen B, Peng C, Xiao W.
europepmc +1 more source
Anti-PLA2R antibody reduction as a predictor of treatment response in primary membranous nephropathy: a retrospective study. [PDF]
Bashir K +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Immunosuppression for membranous nephropathy
The Lancet, 2013Item does not contain ...
Hofstra, J.M., Wetzels, J.
+14 more sources
Segmental membranous nephropathy
Clinical and Experimental Nephrology, 2021Most cases of membranous nephropathy (MGN) present with global and diffuse distribution of subepithelial deposits. However, segmental MGN, in which there is focal or diffuse segmental subepithelial deposits, are occasionally encountered. The clinical and pathologic significance of segmental MGN is not well understood and thought to be more likely due ...
Hae Yoon Grace Choung, Bruce Goldman
openaire +2 more sources
Combined membranous nephropathy and IgA nephropathy
American Journal of Kidney Diseases, 1998IgA nephropathy (IgAN) and membranous nephropathy (MN) are both common renal biopsy findings that rarely have been described together in the same patient. The significance of this finding is not clear. We present the clinical and pathological data of four patients with combined MN-IgAN and discuss possible pathogenetic mechanisms.
M B, Stokes, C E, Alpers
openaire +2 more sources

